Trial intelligence / Profile preview

IV biperiden challenge with donepezil reversal in healthy elderly volunteers

NL-OMON57117Completed

Sponsor
Centre for Human Drug Research
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of biperiden and donepezil (4 arms), sponsored by Centre for Human Drug Research. Primary endpoint: Adaptive tracking performance at 4 hours. Started Jan 2025; status: completed.

02

Drugs

biperidendonepezil

Beyond the preview

Go deeper on NL-OMON57117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON57117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call